Since the beginning of April, EOSS Technologies has been the largest shareholder in the Austrian drug producer Sanochemia Pharmazeutika, with a stake of just under 50%.
After intensive negotiations, a consortium consisting of EOSS, the German radiology specialist b.e. imaging and the Burgenland business development company WiBuG has been awarded the contract to purchase the business via a carve-out. In the process, major parts of Sanochemia Pharmazeutika AG will be transferred to a new company, Sanochemia Pharmazeutika GmbH, based at the previous production site in Neufeld an der Leitha. The economic difficulties of the pharmaceutical company, which was listed on the stock exchange until recently, are now history.
We are boarding here with a renowned company that has been caught in a storm. Our goal is calm waters – and to develop into an innovative, technologically leading Austrian flagship company.”THOMAS ERKINGER, CEO EOSS